Syntr Health Technologies announced positive interim results from its post-market facial fat transfer clinical study. The multi-center study achieved primary endpoints of correction of moderate-to-severe mid-face (cheeks) and nasolabial folds (NLF) volume deficit.
In addition, the study showcased positive safety, volume retention, skin quality improvement, as well as positive patient FACE-Q Satisfaction outcome scoring compared to pre-treatment (baseline).
Facial fat transfer has become increasingly popular in recent years as a safer and more effective alternative to fillers in restoring lost facial volume and enhancing facial contouring. Over 20 patients were enrolled in the study for the correction of age-related cheeks and nasolabial fold volume deficit.
Based on the FACE-Q Satisfaction with Facial Appearance Overall scale results, pre-treatment entry scores indicated that, on average, patients were very dissatisfied or somewhat dissatisfied, with aspects of their facial appearance. After receiving treatment to the cheeks and nasolabial folds, 82% of patients reported being very satisfied or somewhat satisfied with their facial appearance.
"We are thrilled by these results, as they are a testament to the SyntrFuge system's ability to deliver predictable outcomes for patients," said board-certified plastic surgeon and clinical study investigator Dr. Hisham Seify, MD, PhD, FACS. "The data validates the effectiveness of SyntrFuge processed fat tissue as a long-term solution, while maintaining optimal volume retention and achieving natural-looking results for patients."
With the positive outcomes reported, Syntr intends to expand the SyntrFuge system into various Aesthetic indications.